The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| MRD in PAAD Adjuvant Therapy (NCT06867146) | Peking Union Medical College Hospital | 2024-10-15 |
Track The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy automatically
Every clearance here is in the API, with alerts when new ones post.